Earum Pharmaceuticals was incorporated on July 26, 2012. The company is engaged in the pharmaceutical business involving marketing, trading and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic and anti-cold drugs, analgesic/ anti-pyretic and anti-inflammatory drugs, etc.
| Bidding Dates |
|---|
| 21 Jun 2019 - 26 Jun 2019 |
| Subscription |
|---|
| 1.6x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,08,000 | 1 | 1 | 3000 | 1.8 M | ₹36 | 70.04 % | ₹66.5 M | RHP DOC |
Murae Organisor IPO SUBSCRIPTION STATUS
26 Jun '19Murae Organisor IPO overall subscription rate was 1.6 times the total available shares
Murae Organisor IPO retail subscription rate was 1.48 times in the retail segment
Murae Organisor IPO non-institutional investor subscription rate was 1.72 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
25 Jun 2019 (Day 3) | 0.68x | 1.46x | - |
26 Jun 2019 (Day 4) | 1.48x | 1.72x | - |
21 Jun 2019 (Day 1) | 0.02x | 1.16x | - |
24 Jun 2019 (Day 2) | 0.25x | 1.29x | - |
Murae Organisor FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) |
| 9MFY19 | 8.7 | 345.0 | 8.7 | 6.8 |
| FY18 | 8.6 | 354.4 | -62.6 | -63.2 |
| FY17 | 1.6 | 233.4 | 0.9 | 0.7 |
| FY16 | 1.0 | 185.7 | -2.6 | -4.1 |
Murae Organisor IPO SUBSCRIPTION STATUS DETAILS
Murae Organisor had 1.8 M shares on offer
Murae Organisor IPO offer price was ₹36
Murae Organisor IPO minimum Investment was ₹108000
Murae Organisor IPO issue size was ₹ 66.5 M
Murae Organisor had a minimum lot size of 3000 Shares per application
Murae Organisor NUMBER OF SHARES ON OFFER
Murae Organisor IPO IMPORTANT DATES
| Issue Open Date | 21 Jun 2019 |
| Issue close Date | 26 Jun 2019 |
| Allotment Date | 01 Jul 2019 |
| Refund Date | 02 Jul 2019 |
| Demat Account Credit Date | 03 Jul 2019 |
| Listing Date | 04 Jul 2019 |
| Listing on Exchange(s) | BSE |
| Murae Organisor Allotment Status | Exchange |
Murae Organisor IPO subscription opened on 21 Jun 2019, and closed on 26 Jun 2019
IPO allotment for Murae Organisor was finalized on Monday, 01 Jul 2019
IPO listing for Murae Organisor was on BSE on Thursday, 04 Jul 2019
Murae Organisor IPO LISTING GAINS
| Issue Price (adjusted) | 1.6 |
| Listing Open Price | 36.0 |
| Listing Close Price | 36.0 |
| Listing Gain% | 0.0% |
| Current Gain% | -88.4% |
Murae Organisor INFORMATION ON IPO ISSUE
About Murae Organisor
Earum Pharmaceuticals was incorporated on July 26, 2012. The company is engaged in the pharmaceutical business involving marketing, trading and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic and anti-cold drugs, analgesic/ anti-pyretic and anti-inflammatory drugs, etc.
Object of the Issue
- To meet working capital requirements
- General corporate purpose
- To meet issue expenses
Murae Organisor - PROMOTERS
| Name |
|---|
| Bhumishth Narendrabhai Patel |
| Payal Bhumishth Patel |
Murae Organisor Lead Manager of the Issue
Hem Securities Limited
ib@hemsecurities.com
Murae Organisor Registrar to the Offer
Bigshare Services Private Limited
ipo@bigshareonline.com
Murae Organisor Strengths
Diversified product portfolio
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic and anti-cold drugs, analgesic/ antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.
Experienced promoter
The promoter, Bhumishth Narendrabhai Patel has experience of over 12 years in various segments of the pharmaceutical business and has been instrumental in the consistent growth of the company’s performance
Quality assurance
The company's strength lies in understanding the requirements of the customer and its execution capabilities and this has enabled it to get repeated orders from existing customers and attract new customers
Murae Organisor Risks
Dependent on third parties
The company does not own a manufacturing facility and it has to rely on third parties for procuring pharmaceutical products sold by the company
Outstanding legal proceedings
There are certain outstanding legal proceedings filed against the company and any failure to defend these proceedings successfully may have an adverse effect on business prospects, financial condition and result of ongoing operations and reputation
IPO FAQs
The promoters of the company are Bhumishth Narendrabhai Patel and Payal Bhumishth Patel.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 36.0 - 36.0.
The IPO application opens on Jun 21, 2019 and closes on Jun 26, 2019.
The minimum lot size for the IPO is 3000. The maximum lot size for the IPO is 3000.
For all category investors, the minimum application amount for this IPO is Rs. 108,000.0, the maximum value for this IPO is Rs 108,000.0.
This IPO will be allotted on Jul 01, 2019.
The refund will be credited to your account on Jul 02, 2019.
The allotted shares will be credited to your demat on Jul 03, 2019.
Earum Pharmaceuticals Ltd.’s shares listed on the stock exchanges on Jul 04, 2019.